<?xml version="1.0" encoding="UTF-8"?>
<p id="para0019">The proportion of deaths attributable to drugs among PLHCV increased from 15.1% (135/896) in 2010 to 26.1% (322/1274) in 2018. Similarly, the proportion of deaths attributable to drugs among HCV-negative individuals more than doubled from 2010 to 2018, increasing from 3.1% (202/6540) to 8.0% (748/9361).</p>
